Deadline: 11.59 pm AEDT, Tuesday 16 March 2021
Plenary Presentation Opportunity
The four highest scored abstracts submitted for inclusion as free paper in the RMSANZ 2021 program, will be offered the opportunity to present their abstract as part of a plenary session, instead of in a concurrent free paper session.
Successful authors will be given 15 minutes to present, with additional time for Q&A.
This is an excellent, and unique opportunity for abstract authors to present their work in front of a wider audience.
Instructions to submit an abstract for a Free Paper or Poster for inclusion in the RMSANZ 2021 Scientific Program:
Contents should include the following sections:
1. Background and aims: Include one or two sentences to introduce the broad topic area and provide a reason for the study then a clear statement of the study aim. A hypothesis could be included in this section. Reference word counts are included in the word limit and authors are advised to keep references to a minimum by using an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.
2. Methods: In this section information on participants (and /or subjects) should be provided. Data may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Relevant inclusion and exclusion criteria, sample size calculation (if presenting a randomised clinical trial), measures and procedures used in the study are described in this section along with descriptions of analyses.
3. Results: The purpose of the result section is to provide a description of the main study findings. Submitted abstracts must include actual results; reference to inferred results that were unavailable at the time of submission is not acceptable, however, report data from additional recruitment or updated analyses after abstract submission is allowed. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc.).
4. Conclusions: In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.
All presenters must register for a minimum of one day of the conference by the Early Bird Registration Deadline Monday 10 May 2021. Please note, there is no funding, discounted or complimentary registrations available for submitted presenters.